Jim Simons
CRVO icon

Jim Simons’s CervoMed CRVO Stock Holding History

Jim Simons’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63,904
Closed -$252K – 3260
2026
Q1 		$252K Buy
+63,904
New +$334K ﹤0.01% 2860
2024
Q4 		– Sell
-47,933
Closed -$700K – 3627
2024
Q3 		$700K Buy
47,933
+15,600
+48% +$242K ﹤0.01% 2636
2024
Q2 		$554K Buy
32,333
+1,600
+5% +$35K ﹤0.01% 2654
2024
Q1 		$716K Buy
30,733
+1,700
+6% +$22.7K ﹤0.01% 2689
2023
Q4 		$222K Sell
29,033
-200
-0.7% -$1.73K ﹤0.01% 3099
2023
Q3 		$135K Buy
29,233
+2,360
+9% +$11.9K ﹤0.01% 3182
2023
Q2 		$135K Buy
26,873
+800
+3% +$4.65K ﹤0.01% 3398
2023
Q1 		$162K Buy
26,073
+200
+0.8% +$1.77K ﹤0.01% 3349
2022
Q4 		$196K Sell
25,873
-3,466
-12% -$28.9K ﹤0.01% 3431
2022
Q3 		$235K Sell
29,339
-3,176
-10% -$32.2K ﹤0.01% 3313
2022
Q2 		$326K Buy
32,515
+14,859
+84% +$184K ﹤0.01% 3405
2022
Q1 		$331K Buy
17,656
+1,348
+8% +$26.8K ﹤0.01% 3427
2021
Q4 		$373K Buy
16,308
+1,301
+9% +$40.7K ﹤0.01% 3236
2021
Q3 		$574K Sell
15,007
-3,334
-18% -$139K ﹤0.01% 2834
2021
Q2 		$1M Sell
18,341
-5,990
-25% -$331K ﹤0.01% 2665
2021
Q1 		$1.67M Sell
24,331
-13,439
-36% -$1.13M ﹤0.01% 2330
2020
Q4 		$2.25M Sell
37,770
-2,077
-5% -$122K ﹤0.01% 2056
2020
Q3 		$2.52M Sell
39,847
-2,110
-5% -$160K ﹤0.01% 1995
2020
Q2 		$3.07M Buy
41,957
+19,568
+87% +$1.19M ﹤0.01% 1924
2020
Q1 		$532K Buy
22,389
+12,278
+121% +$372K ﹤0.01% 2736
2019
Q4 		$349K Buy
10,111
+8,985
+798% +$549K ﹤0.01% 3029
2019
Q3 		$156K Sell
1,126
-214
-16% -$34.6K ﹤0.01% 3202
2019
Q2 		$286K Sell
1,340
-101
-7% -$27.2K ﹤0.01% 3187
2019
Q1 		$401K Buy
1,441
+750
+109% +$180K ﹤0.01% 3006
2018
Q4 		$103K Buy
691
+405
+142% +$138K ﹤0.01% 3227
2018
Q3 		$139K Buy
286
+99
+53% +$46K ﹤0.01% 3208
2018
Q2 		$96K Buy
187
+58
+45% +$34.3K ﹤0.01% 3151
2018
Q1 		$79K Buy
129
+116
+892% +$101K ﹤0.01% 3278
2017
Q4 		$17K Buy
+13
New +$21.1K ﹤0.01% 3294

Other funds holding CRVO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jim Simons's CRVO Position: Q2 2026 in Review

Jim Simons sold out of CervoMed (CRVO) in Q2 2026, closing a stake of 63,904 shares — an estimated $252K sold.

Jim Simons first reported a position in CRVO in Q4 2017 and held it in 29 quarters. The position peaked at $3.07M in Q2 2020. 29 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Jim Simons reported no remaining CervoMed position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 63,904 CervoMed shares in Q2 2026, an estimated $252K.
  • Jim Simons first reported a position in CervoMed in Q4 2017 and held it in 29 quarters.
  • Jim Simons's CervoMed position peaked at $3.07M in Q2 2020.
  • 29 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.